Diagnostic News and Research

RSS

Advancing knowledge of diet-gene interactions

Josi Ordovas, PhD, director of the Nutrition and Genomics Laboratory at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University joined more than eighty other leading researchers in the fields of nutrition and genetics to co-author a report outlining their strategy for maximizing the impact of nutrigenomics research on global poverty and health.

16 Feb 2006

Risk of Alzheimer's 80% genetic

In the largest twin study to date, researchers in the U.S. looked at the Swedish Twin Registry to see which factors lead to Alzheimer's disease (AD).

14 Feb 2006

Genzyme launches test to monitor Gleevec resistance

Genzyme Corporation has announced the availability of an important new test to monitor drug resistance in chronic myeloid leukemia (CML) patients who are treated with Gleevec (imatinib mesylate).

13 Feb 2006

Grants bring Mesothelioma research to over $3 million

The Mesothelioma Applied Research Foundation has announced thrilling news for all who care about eradicating the vicious disease. MARF has awarded nine new grants of $100,000 each for exciting research projects commencing in late 2005 aimed at curing mesothelioma ("meso").

13 Feb 2006

Gene mutation discovered that causes a rare form of Charcot-Marie-Tooth disease

A multi-national research team that includes a Saint Louis University neurologist has discovered a gene mutation that causes a rare form of Charcot-Marie-Tooth disease, an inherited progressive nerve disorder. The findings are published in an advance online issue of Nature Genetics

13 Feb 2006

Simple diagnostic imaging procedure changes treatment for lower back pain

A simple diagnostic imaging procedure can help identify patients with lower back pain who would benefit from spinal injections and spare those who would not, according to a study appearing in the February issue of Radiology.

13 Feb 2006

Genesis bioventures announces worldwide distribution rights for rapid prion-detection technology

Genesis Bioventures, Inc. has announced that the Company has signed exclusive worldwide sales, marketing and distribution agreements with Prion Developmental Laboratories Inc. (PDL) to commercialize the recently patented Rapid Prion-Detection Assay tests developed by PDL.

7 Feb 2006

Biosense Webster receives FDA approval for technology to treat heart rhythm disease

The U.S. Food and Drug Administration (FDA) today approved an innovative combination of technologies that will enhance a doctors' ability to treat patients with abnormal heart rhythms (cardiac arrhythmias).

7 Feb 2006

Alzheimer disease has a genetic cause in up to 80 percent of cases

"Our finding confirms the higher estimates that have been suggested previously. The important thing is that no one has had this large a sample before," Gatz said, adding the size was 10 times that of any previous study.

7 Feb 2006

CT enteroclysis should replace conventional enteroclysis in patients with Crohn's disease

The diagnostic value of CT enteroclysis is superior to conventional enteroclysis, previously considered the gold standard, as an imaging method for the evaluation of the small bowel in patients with Crohn's disease, a new study shows.

7 Feb 2006

Can marriages be saved by treating snoring?

The husband snores. The wife nudges him to flip over. Both wake up feeling grouchy the next morning. It's a common occurrence that may have more of an impact on the marriage than most couples think.

7 Feb 2006

First description of female-specific Ischemia Syndrome

Although ischemic heart disease - the reduction of blood flow that can lead to heart attacks - is often considered a "man's disease," it takes the lives of more women than men each year. In fact, in 2000, about 60,000 more women than men died from cardiovascular disease.

5 Feb 2006

Phase II clinical trial for new gene transfer drug study

As many as 8-10 million Americans have Peripheral Artery Disease (PAD), by age 70, roughly 20 percent of the population has it, and people with PAD face a six-to-seven times higher risk of heart attack or stroke.

2 Feb 2006

European markets for cardiac catheterisation imaging systems

With a sharp increase in the incidence of cardiovascular disorders and mortalities in Europe, the need for early detection as well as cardiac interventional procedures has created enhanced scope for the uptake of cardiac catheterisation imaging systems.

2 Feb 2006

Scientists more likely to have autistic children

According to an expert in the UK, highly analytical couples such as scientists, engineers, physicists and mathematicians, are more likely to produce children with autism.

31 Jan 2006

8 million children born every year with serious birth defects

According to a new report, every year an estimated 8 million children are born with a serious birth defect of genetic or partially genetic origin.

31 Jan 2006

New biochip predicts evolution of inflammatory bowel disease

The treatment of inflammatory bowel disease, which includes Crohn's disease and ulcerative colitis, has very high costs and can include admissions and surgical interventions. Until now, there was no precise tools to predict the evolution and prognosis of these diseases.

26 Jan 2006

Symposium on celiac disease

A scientific symposium on celiac disease, "Genetic and Immune Mechanisms in Celiac Disease," will be held at the University of California, San Diego (UCSD) School of Medicine on Friday, February 10, from 8:30 a.m. to 12 noon. The symposium, hosted by UCSD’s newly established William K. Warren Medical Research Center for Celiac Disease, will be held at the university’s Center for Molecular Genetics conference room.

23 Jan 2006

Children with autism found to have specific memory problems that may underlie aspects of disorder

If children with autism can't see the forest for the trees, that may be partly because the burden of processing all those trees at once makes it harder to lock in the scene.

23 Jan 2006

Gene therapy to turn off Parkinson's

A group of Northwestern University researchers is developing a novel gene therapy aimed at selectively turning off one of the genes involved in the development of Parkinson's disease.

23 Jan 2006